Integrin-targeted cancer immunotherapy elicits protective adaptive immune responses. [electronic resource]
Producer: 20170918Description: 1679-1690 p. digitalISSN:- 1540-9538
- Adaptive Immunity -- drug effects
- Animals
- Antibody Formation -- drug effects
- Antineoplastic Agents -- pharmacology
- CD4-Positive T-Lymphocytes -- drug effects
- CD8-Positive T-Lymphocytes -- drug effects
- Cell Line, Tumor
- Colonic Neoplasms -- drug therapy
- Cross Reactions -- drug effects
- Dendritic Cells -- drug effects
- Disease Models, Animal
- Female
- Humans
- Immune Tolerance -- drug effects
- Immunotherapy
- Inflammation -- pathology
- Integrins -- metabolism
- Interleukin-2 -- metabolism
- Liver -- drug effects
- Macrophages -- drug effects
- Mice
- Mice, Inbred C57BL
- Peptides -- metabolism
- Receptors, IgG -- metabolism
- Serum Albumin -- metabolism
- Species Specificity
- Tissue Distribution -- drug effects
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.